LGALS3 and cancer: The concentration of galectin-3 is elevated by up to 30-fold in the circulation of cancer patients including those with colon, breast, pancreatic, melanoma, lung, head and neck, and ovarian cancer and non-Hodgkin's lymphoma [2–7].